BMRN Insider Trading

Insider Ownership Percentage: 1.85%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $15,604,519.92

BioMarin Pharmaceutical Insider Trading History Chart

This chart shows the insider buying and selling history at BioMarin Pharmaceutical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioMarin Pharmaceutical Share Price & Price History

Current Price: $65.66
Price Change: Price Increase of +0.66 (1.02%)
As of 12/20/2024 06:15 PM ET

This chart shows the closing price history over time for BMRN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

BioMarin Pharmaceutical Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/12/2024Charles Greg GuyerEVPSell5,278$66.37$350,300.8668,909View SEC Filing Icon  
5/30/2024Brian R. MuellerCFOSell5,000$75.19$375,950.0072,159View SEC Filing Icon  
5/28/2024George Eric DavisEVPSell40,850$74.51$3,043,733.5056,157View SEC Filing Icon  
5/9/2024Jean Jacques BienaimeDirectorSell20,000$81.62$1,632,400.00474,994View SEC Filing Icon  
5/2/2024George Eric DavisEVPSell1,850$85.01$157,268.5056,157View SEC Filing Icon  
4/12/2024Jean Jacques BienaimeDirectorSell20,000$91.26$1,825,200.00474,994View SEC Filing Icon  
4/10/2024Erin BurkhartCAOSell2,286$90.00$205,740.0016,156View SEC Filing Icon  
3/28/2024George Eric DavisEVPSell24,602$88.34$2,173,340.6855,856View SEC Filing Icon  
3/5/2024Henry J. FuchsInsiderSell35,341$85.18$3,010,346.38212,117View SEC Filing Icon  
3/5/2024Jean Jacques BienaimeDirectorSell1,000$85.51$85,510.00561,203View SEC Filing Icon  
3/5/2024Jeffrey Robert AjerEVPSell4,000$87.07$348,280.0094,047View SEC Filing Icon  
2/27/2024Jean Jacques BienaimeDirectorSell1,000$90.35$90,350.00562,203View SEC Filing Icon  
2/9/2024Jean Jacques BienaimeDirectorSell15,000$88.28$1,324,200.00419,602View SEC Filing Icon  
1/9/2024Jean Jacques BienaimeDirectorSell10,000$98.19$981,900.00425,162View SEC Filing Icon  
12/21/2023Jean Jacques BienaimeDirectorSell10,000$93.99$939,900.00425,112View SEC Filing Icon  
12/13/2023George Eric DavisEVPSell13,764$95.30$1,311,709.2055,710View SEC Filing Icon  
8/16/2023Jeffrey Robert AjerEVPSell5,000$90.00$450,000.0060,804View SEC Filing Icon  
8/10/2023Henry J. FuchsInsiderSell12,000$90.43$1,085,160.00176,187View SEC Filing Icon  
8/8/2023George Eric DavisEVPSell11,000$89.42$983,620.0069,474View SEC Filing Icon  
8/7/2023Jean Jacques BienaimeCEOSell4,000$88.10$352,400.00428,732View SEC Filing Icon  
5/10/2023Jean Jacques BienaimeCEOSell30,000$94.85$2,845,500.00426,213View SEC Filing Icon  
4/10/2023Jean Jacques BienaimeCEOSell10,000$99.56$995,600.00425,896View SEC Filing Icon  
4/6/2023Jean Jacques BienaimeCEOSell10,000$96.13$961,300.00425,896View SEC Filing Icon  
4/3/2023V. Bryan LawlisDirectorSell8,500$97.09$825,265.0028,950View SEC Filing Icon  
3/13/2023Jean Jacques BienaimeCEOSell8,000$90.45$723,600.00487,856View SEC Filing Icon  
3/10/2023Jean Jacques BienaimeCEOSell15,000$92.28$1,384,200.00487,856View SEC Filing Icon  
2/13/2023Jean Jacques BienaimeCEOSell6,000$109.15$654,900.00320,324View SEC Filing Icon  
2/10/2023Jean Jacques BienaimeCEOSell15,000$110.11$1,651,650.00320,324View SEC Filing Icon  
1/25/2023Jeffrey Robert AjerEVPSell49,000$115.70$5,669,300.0041,088View SEC Filing Icon  
1/17/2023Jean Jacques BienaimeCEOSell10,000$111.55$1,115,500.00320,424View SEC Filing Icon  
1/13/2023Brian R. MuellerCFOSell2,500$114.50$286,250.0027,746View SEC Filing Icon  
1/13/2023Jean Jacques BienaimeCEOSell10,000$112.25$1,122,500.00320,424View SEC Filing Icon  
12/13/2022Brian R. MuellerCFOSell2,500$107.50$268,750.0027,746View SEC Filing Icon  
12/13/2022Jean Jacques BienaimeCEOSell1,000$106.89$106,890.00320,424View SEC Filing Icon  
12/2/2022Brian R. MuellerCFOSell7,001$104.50$731,604.5027,746View SEC Filing Icon  
12/2/2022Jean Jacques BienaimeCEOSell1,500$103.98$155,970.00321,424View SEC Filing Icon  
11/23/2022Brian R. MuellerCFOSell5,379$98.73$531,068.6728,847View SEC Filing Icon  
11/2/2022Jeffrey Robert AjerEVPSell3,000$86.12$258,360.0041,088View SEC Filing Icon  
10/31/2022Jean Jacques BienaimeCEOSell1,500$86.55$129,825.00322,824View SEC Filing Icon  
10/31/2022Mark J. AllesDirectorBuy3,625$86.75$314,468.7510,905View SEC Filing Icon  
10/14/2022Jean Jacques BienaimeCEOSell4,000$89.89$359,560.00324,324View SEC Filing Icon  
8/15/2022Jean Jacques BienaimeCEOSell3,000$95.21$285,630.00328,324View SEC Filing Icon  
8/12/2022Jean Jacques BienaimeCEOSell4,000$94.75$379,000.00331,324View SEC Filing Icon  
8/11/2022Jeffrey Robert AjerEVPSell3,000$95.62$286,860.0044,088View SEC Filing Icon  
8/8/2022Charles Greg GuyerEVPSell6,205$96.56$599,154.8042,168View SEC Filing Icon  
7/8/2022Brian R. MuellerCFOSell7,337$89.50$656,661.5030,726View SEC Filing Icon  
7/8/2022George Eric DavisEVPSell7,398$90.00$665,820.0058,941View SEC Filing Icon  
5/26/2022Jeffrey Robert AjerEVPSell1,308$78.94$103,253.5254,109View SEC Filing Icon  
5/5/2022Jean Jacques BienaimeCEOSell10,000$84.14$841,400.00335,324View SEC Filing Icon  
5/4/2022Brian R. MuellerCFOSell11,800$84.50$997,100.0038,639View SEC Filing Icon  
5/2/2022George Eric DavisEVPSell15,347$80.38$1,233,591.8666,339View SEC Filing Icon  
5/2/2022Richard A. MeierDirectorSell3,878$82.09$318,345.02104,014View SEC Filing Icon  
4/28/2022Jean Jacques BienaimeCEOSell20,000$83.79$1,675,800.00334,983View SEC Filing Icon  
4/18/2022Jean Jacques BienaimeCEOSell20,000$81.91$1,638,200.00334,983View SEC Filing Icon  
4/14/2022Jean Jacques BienaimeCEOSell10,000$83.66$836,600.00334,983View SEC Filing Icon  
4/14/2022V. Bryan LawlisDirectorSell4,250$83.66$355,555.0023,970View SEC Filing Icon  
4/13/2022Jeffrey Robert AjerEVPSell1,180$82.47$97,314.6055,077View SEC Filing Icon  
3/29/2022Jeffrey Robert AjerEVPSell1,618$79.43$128,517.74View SEC Filing Icon  
3/23/2022Jeffrey Robert AjerEVPSell6,129$81.78$501,229.62View SEC Filing Icon  
3/21/2022George Eric DavisEVPSell6,129$81.29$498,226.41View SEC Filing Icon  
3/10/2022Jean Jacques BienaimeCEOSell15,000$77.57$1,163,550.00View SEC Filing Icon  
2/28/2022Dennis SlamonDirectorSell6,396$78.33$500,998.68View SEC Filing Icon  
1/14/2022V. Bryan LawlisDirectorSell4,250$87.61$372,342.50View SEC Filing Icon  
1/13/2022Jean Jacques BienaimeCEOSell5,000$87.86$439,300.00View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for BioMarin Pharmaceutical (NASDAQ:BMRN)

98.71% of BioMarin Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at BMRN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

BioMarin Pharmaceutical Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/19/2024Principal Financial Group Inc.458,039$32.20M0.0%-29.5%0.240%Search for SEC Filing on Google Icon
12/6/2024Retirement Systems of Alabama231,270$16.26M0.1%-1.3%0.121%Search for SEC Filing on Google Icon
11/25/2024Synovus Financial Corp30,253$2.13M0.0%+25.7%0.016%Search for SEC Filing on Google Icon
11/25/2024Tidal Investments LLC30,467$2.14M0.0%+150.4%0.016%Search for SEC Filing on Google Icon
11/25/2024Sanctuary Advisors LLC21,333$1.37M0.0%-3.2%0.011%Search for SEC Filing on Google Icon
11/20/2024Virtu Financial LLC11,504$0.81M0.0%N/A0.006%Search for SEC Filing on Google Icon
11/18/2024TD Private Client Wealth LLC510$36K0.0%+57.4%0.000%Search for SEC Filing on Google Icon
11/18/2024Teachers Retirement System of The State of Kentucky60,040$4.22M0.0%-69.1%0.032%Search for SEC Filing on Google Icon
11/18/2024Toronto Dominion Bank23,942$1.68M0.0%+31.3%0.013%Search for SEC Filing on Google Icon
11/18/2024Neo Ivy Capital Management21,020$1.48M0.5%+2,225.2%0.011%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC3,260,050$228.63M0.0%+1.9%1.711%Search for SEC Filing on Google Icon
11/15/2024Public Employees Retirement System of Ohio69,113$4.86M0.0%-9.0%0.036%Search for SEC Filing on Google Icon
11/15/2024Nomura Asset Management Co. Ltd.485,609$34.13M0.1%+29.5%0.255%Search for SEC Filing on Google Icon
11/15/2024Y Intercept Hong Kong Ltd28,230$1.98M0.1%N/A0.015%Search for SEC Filing on Google Icon
11/15/2024MML Investors Services LLC7,621$0.54M0.0%+8.1%0.004%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd6,898$0.49M0.0%+37.5%0.004%Search for SEC Filing on Google Icon
11/15/2024Zacks Investment Management17,802$1.25M0.0%-17.5%0.009%Search for SEC Filing on Google Icon
11/15/2024National Bank of Canada FI919$65K0.0%-93.6%0.000%Search for SEC Filing on Google Icon
11/15/2024EP Wealth Advisors LLC7,119$0.50M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/15/2024United Services Automobile Association12,343$0.87M0.0%-16.7%0.006%Search for SEC Filing on Google Icon
11/15/2024Kovitz Investment Group Partners LLC5,081$0.36M0.0%+63.9%0.003%Search for SEC Filing on Google Icon
11/15/2024Worldquant Millennium Advisors LLC63,572$4.47M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/15/2024Wahed Invest LLC4,584$0.32M0.1%+11.4%0.002%Search for SEC Filing on Google Icon
11/15/2024Two Sigma Advisers LP181,314$12.75M0.0%-21.8%0.095%Search for SEC Filing on Google Icon
11/15/2024Stifel Financial Corp30,537$2.15M0.0%-30.6%0.016%Search for SEC Filing on Google Icon
11/15/2024Quarry LP2,500$0.18M0.0%+1,853.1%0.001%Search for SEC Filing on Google Icon
11/15/2024Readystate Asset Management LP5,254$0.37M0.0%-51.8%0.003%Search for SEC Filing on Google Icon
11/15/2024Royal London Asset Management Ltd.77,345$5.44M0.0%+5.5%0.041%Search for SEC Filing on Google Icon
11/15/2024Point72 DIFC Ltd44,484$3.13M0.1%N/A0.023%Search for SEC Filing on Google Icon
11/15/2024Motley Fool Asset Management LLC148,798$10.43M0.6%-1.3%0.078%Search for SEC Filing on Google Icon
11/15/2024Motley Fool Wealth Management LLC424,597$29.85M1.5%-4.7%0.223%Search for SEC Filing on Google Icon
11/15/2024Investment Management Corp of Ontario6,300$0.44M0.0%+50.0%0.003%Search for SEC Filing on Google Icon
11/15/2024Jacobs Levy Equity Management Inc.52,071$3.66M0.0%N/A0.027%Search for SEC Filing on Google Icon
11/15/2024Holocene Advisors LP563,476$39.61M0.2%-21.0%0.296%Search for SEC Filing on Google Icon
11/15/2024Centiva Capital LP7,511$0.53M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/15/2024Clearline Capital LP319,772$22.48M1.0%N/A0.168%Search for SEC Filing on Google Icon
11/15/2024Arizona PSPRS Trust24,100$1.69M0.1%N/A0.013%Search for SEC Filing on Google Icon
11/15/2024Paloma Partners Management Co3,402$0.24M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/15/2024Erste Asset Management GmbH689,935$48.53M0.6%N/A0.362%Search for SEC Filing on Google Icon
11/15/2024True Wealth Design LLC810$57K0.0%+13,400.0%0.000%Search for SEC Filing on Google Icon
11/14/2024Bellevue Group AG330,976$23.26M0.4%+533.7%0.174%Search for SEC Filing on Google Icon
11/14/2024BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp31,676$2.23M0.0%-12.8%0.017%Search for SEC Filing on Google Icon
11/14/2024Edgestream Partners L.P.28,562$2.01M0.1%N/A0.015%Search for SEC Filing on Google Icon
11/14/2024PDT Partners LLC33,028$2.32M0.2%N/A0.017%Search for SEC Filing on Google Icon
11/14/2024Fred Alger Management LLC26,573$1.87M0.0%-10.0%0.014%Search for SEC Filing on Google Icon
11/14/2024Captrust Financial Advisors10,900$0.77M0.0%+34.1%0.006%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP400,000$28.12M2.1%N/A0.210%Search for SEC Filing on Google Icon
11/14/2024Rockefeller Capital Management L.P.266,633$18.74M0.1%+16.5%0.140%Search for SEC Filing on Google Icon
11/14/2024Martingale Asset Management L P50,878$3.58M0.1%-12.2%0.027%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC880,453$61.89M0.0%-13.1%0.462%Search for SEC Filing on Google Icon
11/14/2024FORA Capital LLC25,399$1.79M0.2%+199.8%0.013%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC98,372$6.92M0.0%-1.6%0.052%Search for SEC Filing on Google Icon
11/13/2024Glenmede Trust Co. NA3,614$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/13/2024Bridgewater Associates LP142,314$10M0.1%+306.8%0.075%Search for SEC Filing on Google Icon
11/13/2024Freedom Investment Management Inc.4,838$0.34M0.0%-6.7%0.003%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets150,364$10.57M0.0%-77.9%0.079%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP2,427$0.17M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/13/2024FMR LLC206,538$14.52M0.0%+21.7%0.108%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company159,917$11.24M0.0%-11.5%0.084%Search for SEC Filing on Google Icon
11/13/2024Dynamic Technology Lab Private Ltd14,376$1.01M0.1%N/A0.008%Search for SEC Filing on Google Icon
11/13/2024Daiwa Securities Group Inc.18,006$1.27M0.0%+7.0%0.009%Search for SEC Filing on Google Icon
11/12/2024Alpha DNA Investment Management LLC6,618$0.47M0.2%N/A0.003%Search for SEC Filing on Google Icon
11/12/2024Swedbank AB388,529$27.31M0.0%+34.7%0.204%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.1,401,628$98.52M0.0%+4.1%0.735%Search for SEC Filing on Google Icon
11/9/2024Primecap Management Co. CA18,867,435$1.33B1.0%+0.4%9.900%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC53,856$3.79M0.0%-7.2%0.028%Search for SEC Filing on Google Icon
11/8/2024King Luther Capital Management Corp28,840$2.03M0.0%N/A0.015%Search for SEC Filing on Google Icon
11/8/2024Grandfield & Dodd LLC16,661$1.17M0.1%+2.6%0.009%Search for SEC Filing on Google Icon
11/8/2024EULAV Asset Management131,000$9.21M0.2%+12.9%0.069%Search for SEC Filing on Google Icon
11/8/2024Advisors Asset Management Inc.11,451$0.81M0.0%+1.6%0.006%Search for SEC Filing on Google Icon
11/8/2024Connor Clark & Lunn Investment Management Ltd.116,257$8.17M0.0%N/A0.061%Search for SEC Filing on Google Icon
11/8/2024Howe & Rusling Inc.49,652$3.49M0.3%+101.2%0.026%Search for SEC Filing on Google Icon
11/8/2024Commerce Bank4,707$0.33M0.0%-45.6%0.002%Search for SEC Filing on Google Icon
11/8/2024B. Metzler seel. Sohn & Co. Holding AG4,889$0.34M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/8/2024Banque Cantonale Vaudoise16,000$1.13M0.0%-2.1%0.008%Search for SEC Filing on Google Icon
11/7/2024Meeder Asset Management Inc.735$52K0.0%+920.8%0.000%Search for SEC Filing on Google Icon
11/7/2024Quest Partners LLC4,336$0.31M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/7/2024Swiss National Bank563,600$39.62M0.0%+0.3%0.296%Search for SEC Filing on Google Icon
11/7/2024AM Squared Ltd1,400$98K0.2%+75.0%0.001%Search for SEC Filing on Google Icon
11/6/2024Mutual of America Capital Management LLC102,894$7.23M0.1%-5.4%0.054%Search for SEC Filing on Google Icon
11/6/2024Comgest Global Investors S.A.S.10,147$0.71M0.0%-93.4%0.005%Search for SEC Filing on Google Icon
11/6/2024Simplify Asset Management Inc.8,489$0.60M0.0%+67.5%0.004%Search for SEC Filing on Google Icon
11/6/2024CIBC Asset Management Inc6,731$0.47M0.0%+5.6%0.004%Search for SEC Filing on Google Icon
11/6/2024OneDigital Investment Advisors LLC5,078$0.36M0.0%-22.9%0.003%Search for SEC Filing on Google Icon
11/6/2024Tokio Marine Asset Management Co. Ltd.21,105$1.48M0.1%+0.8%0.011%Search for SEC Filing on Google Icon
11/6/2024Metis Global Partners LLC5,450$0.38M0.0%+9.7%0.003%Search for SEC Filing on Google Icon
11/5/2024Rakuten Securities Inc.1,260$89K0.0%+125,900.0%0.001%Search for SEC Filing on Google Icon
11/5/2024Sumitomo Mitsui Trust Group Inc.456,097$32.06M0.0%+4.7%0.239%Search for SEC Filing on Google Icon
11/5/2024OVERSEA CHINESE BANKING Corp Ltd3,498$0.25M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/5/2024WCM Investment Management LLC16,945$1.20M0.0%+162.3%0.009%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC10,098$0.71M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/4/2024Crossmark Global Holdings Inc.13,322$0.94M0.0%+20.6%0.007%Search for SEC Filing on Google Icon
11/2/2024Covestor Ltd1,030$72K0.0%+336.4%0.001%Search for SEC Filing on Google Icon
11/1/2024AIA Group Ltd3,435$0.24M0.0%+15.4%0.002%Search for SEC Filing on Google Icon
10/31/2024Principal Financial Group Inc.458,039$32.20M0.0%-29.5%0.241%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank90,666$6.37M0.1%-5.5%0.048%Search for SEC Filing on Google Icon
10/30/2024Stoneridge Investment Partners LLC4,190$0.30M0.1%N/A0.002%Search for SEC Filing on Google Icon
10/30/2024AlphaCentric Advisors LLC32,500$2.28M1.7%+97.0%0.017%Search for SEC Filing on Google Icon
10/30/2024Gulf International Bank UK Ltd14,824$1.04M0.0%-5.1%0.008%Search for SEC Filing on Google Icon
10/30/2024Asset Management One Co. Ltd.76,502$5.38M0.0%-1.6%0.040%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
BioMarin Pharmaceutical logo
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops Roctavian, an adeno associated virus vector, for the treatment of patients with severe hemophilia A. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc. The company was incorporated in 1996 and is headquartered in San Rafael, California.
Read More on BioMarin Pharmaceutical

Today's Range

Now: $65.66
Low: $64.07
High: $66.27

50 Day Range

MA: $66.58
Low: $61.93
High: $70.53

52 Week Range

Now: $65.66
Low: $61.15
High: $99.25

Volume

3,974,318 shs

Average Volume

1,808,870 shs

Market Capitalization

$12.51 billion

P/E Ratio

39.32

Dividend Yield

N/A

Beta

0.29

Who are the company insiders with the largest holdings of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top insider shareholders include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Jeffrey Robert Ajer (EVP)
  5. Brian Mueller (CFO)
  6. George Eric Davis (EVP)
  7. Charles Greg Guyer (EVP)
  8. V Bryan Lawlis (Director)
  9. Erin Burkhart (CAO)
Learn More about top insider investors at BioMarin Pharmaceutical.

Who are the major institutional investors of BioMarin Pharmaceutical?

BioMarin Pharmaceutical's top institutional investors include:
  1. Primecap Management Co. CA — 9.90%
  2. Geode Capital Management LLC — 1.71%
  3. Charles Schwab Investment Management Inc. — 0.74%
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 0.46%
  5. Erste Asset Management GmbH — 0.36%
  6. Swiss National Bank — 0.30%
Learn More about top institutional investors of BioMarin Pharmaceutical stock.

Which major investors are selling BioMarin Pharmaceutical stock?

During the previous quarter, BMRN stock was sold by these institutional investors:
  1. BNP Paribas Financial Markets
  2. Jane Street Group LLC
  3. Assenagon Asset Management S.A.
  4. Principal Financial Group Inc.
  5. Principal Financial Group Inc.
  6. Holocene Advisors LP
  7. Comgest Global Investors S.A.S.
  8. Teachers Retirement System of The State of Kentucky
During the previous year, company insiders that have sold BioMarin Pharmaceutical company stock include:
  1. Jean Jacques Bienaime (Director)
  2. Jean Jacques Bienaime (CEO)
  3. Henry J Fuchs (Insider)
  4. Jeffrey Robert Ajer (EVP)
  5. Brian Mueller (CFO)
  6. George Eric Davis (EVP)
  7. Charles Greg Guyer (EVP)
Learn More investors selling BioMarin Pharmaceutical stock.

Which major investors are buying BioMarin Pharmaceutical stock?

During the last quarter, BMRN stock was bought by institutional investors including:
  1. Erste Asset Management GmbH
  2. Vestal Point Capital LP
  3. Clearline Capital LP
  4. Bellevue Group AG
  5. Robeco Institutional Asset Management B.V.
  6. Connor Clark & Lunn Investment Management Ltd.
  7. Nomura Asset Management Co. Ltd.
  8. LMR Partners LLP